[HTML][HTML] Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls

JR Verani, AH Baqui, CV Broome, T Cherian, C Cohen… - Vaccine, 2017 - Elsevier
Case-control studies are commonly used to evaluate effectiveness of licensed vaccines after
deployment in public health programs. Such studies can provide policy-relevant data on …

[HTML][HTML] Case-control vaccine effectiveness studies: Data collection, analysis and reporting results

JR Verani, AH Baqui, CV Broome, T Cherian, C Cohen… - Vaccine, 2017 - Elsevier
The case-control methodology is frequently used to evaluate vaccine effectiveness post-
licensure. The results of such studies provide important insight into the level of protection …

Effectiveness of pneumococcal conjugate vaccines (PCV7 and PCV13) against invasive pneumococcal disease among children under two years of age in Germany

M van der Linden, G Falkenhorst, S Perniciaro… - PloS one, 2016 - journals.plos.org
Background In this study we calculate the effectiveness of pneumococcal conjugate
vaccines (PCV) against invasive pneumococcal disease (IPD) among children under the …

[PDF][PDF] Electronic immunization registries in Latin America: progress and lessons learned

MC Danovaro-Holliday, C Ortiz… - … de Salud Pública, 2014 - SciELO Public Health
Most of the current vaccination coverage monitoring in Latin America relies on aggregated
data. Improved monitoring has been shown to result in better coverage. Taking advantage of …

Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country

G García Gabarrot, M López Vega, G Pérez Giffoni… - PLoS one, 2014 - journals.plos.org
Background In 2008, a 7-valent pneumococcal conjugate vaccine (PCV7) was introduced
into the routine childhood immunization program in Uruguay, with a 2+ 1 schedule. In 2010 …

The Saudi thoracic society pneumococcal vaccination guidelines-2016

NS Alharbi, AM Al-Barrak, MS Al-Moamary… - Annals of thoracic …, 2016 - journals.lww.com
Streptococcus pneumoniae (pneumococcus) is the leading cause of morbidity and mortality
worldwide. Saudi Arabia is a host to millions of pilgrims who travel annually from all over the …

Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned

LH de Oliveira, SP Trumbo, C Ruiz Matus… - Expert review of …, 2016 - Taylor & Francis
ABSTRACT In Latin America and the Caribbean, pneumococcus has been estimated to
cause 12,000-28,000 deaths, 182,000 hospitalizations, and 1.4 million clinic visits annually …

[HTML][HTML] Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean 2010–2015: A systematic review and a time series analysis

CI Agudelo, R DeAntonio, E Castaneda - Vaccine, 2018 - Elsevier
Background This systematic review aims to describe the prevalence, trends, and antibiotic
resistance of Streptococcus pneumoniae serotype 19A (Spn19A) that causes invasive and …

[HTML][HTML] Etiología y evolución de las infecciones osteo-articulares 2009-2015: Hospital Pediátrico del Centro Hospitalario Pereira Rossell, Uruguay

C Zuníno, A Vomero, S Pandolfo, C Gutiérrez… - Revista chilena de …, 2017 - SciELO Chile
Introducción: El agente etiológico más frecuente de las infecciones osteoarticulares (IOA) es
Staphylococcus aureus. Luego de la introducción de nuevas vacunas la prevalencia de …

Effectiveness of different vaccine schedules for heptavalent and 13-valent conjugate vaccines against pneumococcal disease in the Community of Madrid

P Latasa, M Ordobás, M Garrido-Estepa, AG De Miguel… - Vaccine, 2017 - Elsevier
Introduction The heptavalent pneumococcal conjugate vaccine (PCV-7) was added to the
childhood routine vaccination program in the Community of Madrid in November of 2006 …